How to Help Your Patients Save Money on Likmez: A Provider's Guide to Savings Programs

Likmez (metronidazole oral suspension 500 mg/5 mL) has an important clinical role — but its retail price of $207–$246 can be a significant barrier for patients, particularly those without adequate insurance or facing prior authorization delays. Prescription abandonment at the pharmacy is a real risk when patients see the out-of-pocket cost. This guide equips providers with practical tools to address cost barriers proactively.

Understanding the Cost Landscape for Likmez

Likmez is a brand-name specialty product with no current FDA-approved generic equivalent. As of 2026:

• Retail price: $207–$246 per 75 mL bottle (500 mg/5 mL)
• GoodRx discounted price: ~$213 at participating pharmacies
• Comparator: Generic metronidazole 500 mg tablets: $5–$10 with GoodRx coupon for a full course
• Insurance coverage: Varies widely; often requires prior authorization; placed on higher formulary tiers (Tier 3+)

The significant cost difference between Likmez and generic tablets means it's worth addressing cost at the prescribing visit — before the patient reaches the pharmacy and considers abandoning the prescription.

Strategy 1: Prescribe Likmez Only When Clinically Necessary

The first savings strategy is ensuring Likmez is prescribed only when clinically indicated — i.e., when the liquid formulation provides a meaningful clinical benefit over generic tablets. Appropriate indications for prescribing Likmez over generic tablets include:

• Documented dysphagia or swallowing disorder (ICD-10 R13.x)
• Patients with nasogastric or gastrostomy tubes
• Pediatric patients requiring amebiasis treatment (FDA-approved indication)
• Documented tablet adherence failure due to difficulty swallowing or severe taste aversion
• Cases where FDA-approved formulation is preferred over compounded liquid metronidazole for safety/quality reasons

Strategy 2: Proactively Pursue Prior Authorization

Most payers require prior authorization for Likmez because of generic metronidazole tablet availability. A proactive PA submission with the prescription — rather than waiting for a pharmacy rejection — significantly speeds up the process and reduces patient wait times.

Key documentation elements for a successful Likmez PA:

• ICD-10 code for the infection being treated (A59.01, A06.0, K65.0, etc.)
• ICD-10 code for the condition requiring liquid formulation (R13.x for dysphagia, or similar)
• Statement of medical necessity: why liquid formulation is required vs. tablets
• If step therapy is required: documentation that tablets were tried and failed (if applicable)
• Supporting clinical notes (swallowing evaluation, relevant diagnoses, medication history)

Strategy 3: Connect Patients with GoodRx or SingleCare

For patients paying out-of-pocket or when GoodRx price is lower than insurance copay, a GoodRx coupon reduces Likmez from ~$246 retail to ~$213. Print or digitally share the GoodRx coupon with the patient at the point of care, or direct them to goodrx.com/likmez.

Remind patients that GoodRx coupons cannot be combined with insurance — patients should compare their insurance copay with the GoodRx price and use whichever is lower.

Strategy 4: Refer to Manufacturer Patient Assistance

Saptalis Pharmaceuticals may have patient assistance programs (PAP) for uninsured or underinsured patients who cannot afford Likmez. Direct patients to:

• Phone: 1-833-727-8254
• Email: info@saptalis.com
• Website: likmez.com

Your practice's social work or care coordination team may be able to assist with the PAP enrollment process, especially for elderly or low-income patients.

Strategy 5: Consider Generic Metronidazole When Appropriate

For patients who can take tablets, generic metronidazole 500 mg tablets are the most cost-effective option. At $5–$10 for a full course vs. $207–$246 for Likmez, this substitution can save patients substantial out-of-pocket expense. Consider documenting in the prescription: "Metronidazole 500 mg tablets acceptable if patient tolerates oral solids" — this gives the pharmacist flexibility in cases where Likmez is unavailable or the patient hesitates at the cost.

Strategy 6: Reduce Prescription Abandonment with medfinder

Even when cost is addressed, pharmacy availability is another abandonment risk for Likmez. medfinder for Providers enables your practice to help patients find Likmez at an in-stock pharmacy, reducing the chance they give up on filling the prescription entirely.

Provider Action Checklist at Prescribing Visit

• Confirm clinical need for liquid formulation (document in chart)
• Check patient's insurance formulary tier and PA requirements before writing the prescription
• Submit PA proactively if required by patient's plan
• Share GoodRx coupon info (goodrx.com/likmez) with the patient
• Provide Saptalis PAP contact (1-833-727-8254) for low-income or uninsured patients
• Counsel patient that not all pharmacies carry Likmez; advise them to use medfinder to check stock
• Document alternative prescription plan in chart (generic tablets or compounded suspension if Likmez is unavailable or too costly)

Also see: How to Help Your Patients Find Likmez in Stock: A Provider's Guide for pharmacy access strategies.